-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:我們將12個月目標價從30美元調整至27美元。這項調整是基於我們對2026年每股盈餘(EPS)預測的9.1倍本益比。此目標價高於其五年歷史平均預期本益比6.4倍,其獲利能力的提升、獲利韌性和資本回報的可見度均足以支撐此一溢價。我們維持2026年每股收益0.55英鎊和2027年每股收益0.62英鎊的預測。我們之所以維持「買入」評級,是基於2026年第一季強勁的業績表現,這也證明了該銀行雄心勃勃的策略計畫。巴克萊銀行展現了驚人的韌性,吸收了約3.33億英鎊的重大一次性支出,其中包括2.28億英鎊的欺詐相關減值和1.05億英鎊的汽車金融撥備,同時仍保持了13.5%的穩健股本回報率。管理層宣布新的5億英鎊股票回購計劃,再次重申了對股東回報的承諾,並顯著增強了其在2026年至2028年間向股東分配超過150億英鎊的多年期計劃的可信度。
Related Articles
MOG Digitech Chairman Resigns; Co-CEO Assumes CEO Role
MOG Digitech (HKG:1942) announces Deng Zhihua's resignation as its chairman and co-CEO effective Tuesday.The move allows Mr. Deng to dedicate more time to his other commitments, according to a Tuesday Hong Kong bourse filing.Shares of the fintech company were up 1% in Wednesday afternoon trading.Co-CEO Chen Yongzhong was also appointed as the company's CEO, starting on the same day.The firm is currently in the process of identifying a suitable candidate for the chair position.
Genertec Universal Medical's Profit Rises 5% in Q1
Genertec Universal Medical (HKG:2666) said profit attributable to ordinary shareholders rose about 4.8% year over year in the first quarter, according to a Hong Kong bourse filing.Revenue fell about 4.5% from a year earlier.The group said its integrated healthcare business saw outpatient and emergency visits rise about 4.5% year over year, while health check-up revenue increased about 13.3%.